ANI Pharmaceuticals
NasdaqGM:ANIP Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
WA
Consensus Narrative from 6 Analysts
New Clinical Trials Will Expand ILUVIEN And YUTIQ Market Presence In 2025
Key Takeaways Successful Alimera acquisition integration is set to enhance financial metrics and drive notable EPS growth. Cortrophin Gel's growth, driven by new developments and market expansion, is poised to significantly boost revenue in coming years.
View narrativeUS$78.67
FV
25.2% undervalued intrinsic discount13.01%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
about 1 month ago author updated this narrative